Cart
sales@molnova.com
Home - Products - Cytoskeleton/Cell Adhesion Molecules - Microtubule/Tubulin - 4-Isopropoxybenzoic acid

4-Isopropoxybenzoic acid

CAS No. 13205-46-4

4-Isopropoxybenzoic acid( AI3-12104 | AI3 12104 | AI312104 )

Catalog No. M27802 CAS No. 13205-46-4

4-Isopropoxybenzoic acid is a Centromere-Associated Protein E inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 32 In Stock
25MG 56 In Stock
50MG 77 In Stock
100MG 111 In Stock
200MG 166 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    4-Isopropoxybenzoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Isopropoxybenzoic acid is a Centromere-Associated Protein E inhibitor.
  • Description
    4-Isopropoxybenzoic acid is a Centromere-Associated Protein E inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AI3-12104 | AI3 12104 | AI312104
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Microtubule/Tubulin
  • Recptor
    EED|PRC2|Ligands for Target Protein for PROTAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13205-46-4
  • Formula Weight
    180.203
  • Molecular Formula
    C10H12O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)Oc1ccc(cc1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Potjewyd F, et al. Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader. Cell Chem Biol. 2020 Jan 16;27(1):47-56.e15.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Paclitaxel

    Paclitaxel is a novel antineoplastic agent, which was discovered in a screen of extracts of thousands of plants and natural products for antineoplastic activity by a National Y Institute program.

  • Vinflunine

    The behavior of vinflunine in routine clinical practice resembles that of the pivotal phase III randomized study. Vinflunine（VFL）-EPR combination is feasible with manageable toxicity.

  • Deoxypodophyllotoxin

    Deoxypodophyllotoxin shows cytotoxic , antineoplastic, antitumor, insecticidal, anti-angiogenic, vascular disrupting, insecticidal, antiviral, and anti-inflammatory activities.Deoxypodophyllotoxin (DPT) induced both apoptosis and autophagy via production of mitochondrial reactive oxygen species (ROS).?

Sign In Join Free